This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Pharma Clinical Trial Services: World Market 2013-2023

NextGen Sciences

Nexus Oncology

NHS Research Scotland (NRS)

OCT

Omnicare

Ontario Teachers' Pension Plan

Oxford Cancer Biomarkers

Oxford Gene Technology (OGT)

Oxford Outcomes (part of ICON)

Pacific Biomarkers

Paragon Biomedical (part of Clinipace Worldwide)

Paramax International (part of RPS)

Parexel International

Perceptive Informatics (part of Parexel)

PFC Pharma Focus (part of Clinipace Worldwide)

Pfizer

Pharmaceutical Research and Manufacturers of America (PhRMA)

Pharmaceuticals and Medical Devices Agency (PMDA) [ Japan]

PharmaNet Development Group (part of inVentiv Health)

PPD

PRA International

Prana Biotechnology

PriceSpective (part of ICON)

Prodia Clinical Laboratory

Proteome Sciences

ProTrials Research

Psychmed (part of The Cognition Group)

QED Clinical Services

Quintiles

Regulus Pharmaceutical Consulting (part of Clinipace Worldwide)

ReSearch Pharmaceutical Services (RPS)

Rules Based Medicine (now Myriad RBM, part of Myriad Genetics)

Samsung

SAS

Shanghai Clinical Research Center

ShangPharma

Shire

State Food and Drug Administration (SFDA) [China]

Sugi Medical Co (part of CMIC)

Taijitu Biologics

Tessella

The Carlyle Group

The Cognition Group

Theorem Clinical Research

Theradex Systems

Therapeutic Goods Administration (TGA) [ Australia]

Therapharm Recherches (part of RPS)

Thomas H. Lee Partners

Tigermed Consulting

Timaq Medical Imaging (part of ICON)

Trident Clinical Research (part of INC Research)

UCB

Veeda Clinical Research

Vigiun (part of Chiltern International)

VirtualScopics

Warburg Pincus

West Coast Clinical Trials (WCCT)

World Health Organization (WHO)

Worldwide Clinical Research

WuXi AppTec

WuXi PharmaTech

To order this report: Drug_Discovery_and_Development Industry: Pharma Clinical Trial Services: World Market 2013-2023

Contact Clare: clare@reportlinker.comUS:(339) 368 6001Intl:+1 339 368 6001

 

SOURCE Reportlinker

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
13 of 13

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs